Skip to main content
. 2016 Nov 2;12(6):5315–5320. doi: 10.3892/ol.2016.5336

Figure 1.

Figure 1.

TGFβ1 treatment increases the sphere-forming ability of HNSCC K3 CSCs. (A) Photomicrographs of representative spheres after exogenous TGFβ1 or control (dimethyl sulfoxide) treatment in HNSCC CSCs, (B) with quantification. Scale bar, 30 µM. **P<0.01. TGFβ1, transforming growth factor β; HNSCC, head and neck squamous cell carcinoma; CSCs, cancer stem cells.